genection (@genection) profile picture

genection

@genection

Everybody has a story.

genection.com
Joined May 2012
  • Tweets1.2K
  • Following1K
  • Followers428
71Media
Photo by genection (@genection)Photo by genection (@genection)Photo by genection (@genection)Photo by genection (@genection)Photo by genection (@genection)Photo by genection (@genection)Photo by genection (@genection)Photo by genection (@genection)Photo by genection (@genection)
In the US Holocaust Museum. -SR
Image from Globalflyguy (@NYflightguy)
231
23,023
1,691
29,741
#PMWC17 2:45pm: Importance of Design Controlled Assays in Hematopathology by @BradPatay @Genection #genomics #genes ow.ly/EVWx308f82R
1
First NGS Companion Test to Get FDA Nod genomeweb.com/molecular-diag…

Foundation BRCA CDx is First NGS Companion Test to Get FDA Nod

The test is approved to identify patients who harbor BRCA mutations and are therefore more likely to respond to Clovis Oncology's ovarian cancer drug Rubraca.

genomeweb.com
Biomarker Predicts Fatal Leukemia Development in Previously Treated Cancer Patients genengnews.com/gen-news-high… via @genbio
As Humira readies for biosimilar rivals, AbbVie looks to ASH to build oncology momentum fiercepharma.com/pharma/as-h…
A major contributor to AML has left us--European Hematology Association @EHA ehaweb.org/news/eha-news/eha…
CRISPR Screen Finds New Potential Leukemia Drug Target genengnews.com/gen-news-high… via @genbio
MRD Assessment Improves Prediction of Outcome in Patients With CLL Who Achieve Partial Response jco.ascopubs.org/content/ear…
Fierce Women in Biopharma 2016 fiercepharma.com/special-rep…
Fierce Women in Biopharma 2016

Fierce Women in Biopharma 2016

2016 has been a trailblazing year for women--not just on the political scene, where Hillary Clinton in July became the first woman to snag a nomination for president from a major U.S. political...

fiercepharma.com
AML: Evidence Weak for Maintenance in Adults in CR medpagetoday.com/reading-roo…
Kite Unveils Anticipated CAR-T Cancer Data: Positive But Not Complete xconomy.com/national/2016/09… via @xconomy
Safe, Effective Therapy for Older Patients With AML, CLL medpagetoday.com/MeetingCove…
Hypomethylating Agents Useful in Low-Risk MDS medpagetoday.com/MeetingCove…
Novel Antibodies Homing in on New Targets for AML, MDS medpagetoday.com/reading-roo…
AML: Beware of Pre-leukemic Clones Surviving Chemotherapy medpagetoday.com/reading-roo…
BBC News - A decade on, vaccine has halved cervical cancer rate bbc.com/news/world-australia…
Midostaurin in AML: 1st Targeted Agent Improves Survival & @invivoscribe is the CDx developer medscape.com/viewarticle/855… via @medscape
AML: Conjugate Produces High Remission Rates in Older Patients medpagetoday.com/reading-roo…
'Miracle' gene therapy offers hope for girl with 'childhood Alzheimer's' today.com/health/saving-eliz… via @todayshow
'Miracle' gene therapy offers hope for girl with 'childhood Alzheimer's'

'Miracle' gene therapy offers hope for girl with 'childhood Alzheimer's'

Eliza O'Neill's parents call it their miracle. She's finally the first patient to receive an experimental therapy for her deadly disease.

today.com
Load more